-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NIrWHLppjBJx3FcqMXchvassmlZJrS/9pF7/PrwVw1xv4EobV70PSv7v7YOtQE58 VljOlHQZ6d3FnyxdzG8uNA== /in/edgar/work/20000804/0000920691-00-000007/0000920691-00-000007.txt : 20000921 0000920691-00-000007.hdr.sgml : 20000921 ACCESSION NUMBER: 0000920691-00-000007 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000804 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-59397 FILM NUMBER: 686167 BUSINESS ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584537200 MAIL ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TRIPOS INC CENTRAL INDEX KEY: 0000920691 STANDARD INDUSTRIAL CLASSIFICATION: [7372 ] IRS NUMBER: 431454986 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1699 SOUTH HANLEY RD STREET 2: STE 303 CITY: ST LOUIS STATE: MO ZIP: 63144 BUSINESS PHONE: 3146471099 MAIL ADDRESS: STREET 1: 1699 SOUTH HANLEY RD STREET 2: STE 303 CITY: ST LOUIS STATE: MO ZIP: 63144 SC 13G 1 0001.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___)* Arena Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $.0001 per share (Title of Class of Stock) 040047 10 2 (CUSIP Number) July 28, 2000 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 040047 10 2 _____________________________________________________________ 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON TRIPOS, INC. 43-1454986 _____________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] _____________________________________________________________ 3 SEC USE ONLY _____________________________________________________________ 4 CITIZENSHIP OR PLACE OF ORGANIZATION UTAH _____________________________________________________________ 5 SOLE VOTING POWER NUMBER OF SHARES 2,015,840 _____________________________________________________________ 6 SHARED VOTING POWER BENEFICIALLY OWNED BY None _____________________________________________________________ 7 SOLE DISPOSITIVE POWER EACH REPORTING 2,015,840 _____________________________________________________________ 8 SHARED DISPOSITIVE POWER PERSON WITH None _____________________________________________________________ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,015,840 _____________________________________________________________ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] _____________________________________________________________ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.3% _____________________________________________________________ 12 TYPE OF REPORTING PERSON* CO _____________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1(a) Name of Issuer: Arena Pharmaceuticals, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 6166 Nancy Ridge Drive San Diego, CA 92121 Item 2(a) Name of Person Filing: Tripos, Inc. Item 2(b) Address of Principal Business Office 1699 South Hanley Road St. Louis, MO 63144 Item 2(c) Citizenship: Tripos, Inc. is a Utah corporation with its principal offices in Missouri Item 2(d) Title of Class of Securities: Common Stock, par value $.0001 per share Item 2(e) CUSIP Number: 040047 10 2 Item 3. If this statement is filed pursuant to 240.13d- 1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19)of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with 240.13d (b)(1)(ii)(J). If this statement is filed pursuant to 240.13d-1(c), check this box. [ ] Item 4. Ownership: Amount Beneficially Owned: 2,015,840 Percent of Class: 9.3% Number of shares as to such persons has: (i) sole power to vote or to direct the vote: 2,015,840 (ii) shared power to vote or to direct the vote: none (iii)sole power to dispose or to direct the disposition of:2,015,840 (iv) shared power to dispose or to direct the disposition of: none Item 5. Ownership of Five Percent or Less of a Class: Not applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person: Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not applicable Item 8. Identification and Classification of Member of the Group: Not applicable Item 9. Notice of Dissolution of Group: Not applicable Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated August 8, 2000 TRIPOS, INC. By: /s/ John P. McAlister /s/ Colleen A. Martin Chief Executive Officer Chief Financial Officer Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations. (See 18 U.S.C. 1001) -----END PRIVACY-ENHANCED MESSAGE-----